Crystal Research Associates has issued a 10-page Company Update on BacTech Environmental Corporation
(CSE: BAC | OTCQB: BCCEF | FSE: 0BT1) following the release of their recent news and financial results.
Snapshot
BacTech Environmental Corporation (“BacTech” or “the Company”) is a Canadian-based cleantech company that has spent more than three decades developing and applying bioleaching to difficult mineral concentrates and mine waste. Management describes the business as “our bugs eat rocks,” reflecting the use of naturally occurring bacteria to oxidize sulphide minerals, liberate metals, and neutralize harmful toxins, such as arsenic, in an atmospheric, water-based process. Using its proprietary BACOX® bioleaching technology, BacTech targets arsenic-rich concentrates and tailings (finely ground mine waste left after mineral extraction), converting long-standing environmental liabilities into stable, saleable products. The Company has built three commercial bioleach plants for gold under prior licensing arrangements in Western Australia, Tasmania, and China, and is now advancing an owner-operated bioleach facility in the Tenguel-Ponce Enríquez region of Ecuador, focused on refractory gold concentrates and arsenic-bearing materials. In parallel, BacTech is developing its patent-pending “Zero Tailings™” process, the Company’s initiative to treat historic tailings, recover metal values and co-products such as iron and sulphur, and leave behind inert silica (sand), with the goal of building a network of modular bioleaching and zero tailings facilities that can clean up legacy mining waste while generating solid economic returns.
Key Points of BacTech Environmental Corporation
- BacTech’s core opportunity is built around converting difficult-to-treat mining materials into saleable products while reducing long-term environmental liabilities. Its BACOX® bioleaching technology targets arsenic-rich concentrates, including through the Company’s planned Tenguel project in Ecuador, while its Zero Tailings™ platform is designed to recover critical minerals, magnetite, fertilizer, and silica from legacy tailings.
- During the quarter, BacTech strengthened its Zero Tailings™ IP position through national patent filings in Canada and the U.S., followed by a May 2026 provisional patent upgrade adding reverse osmosis pre-concentration and mechanical vapour recompression evaporation to the flowsheet. The enhancement is intended to improve the economics of producing specification-grade ammonium sulphate fertilizer from dilute mining-derived streams and broaden the technology’s potential licensing market across hydrometallurgical operations.
- BacTech is advancing its planned Tenguel bioleach facility and Zero Tailings™ platform from development toward commercialization. Key milestones are expected to include securing project-level financing for Tenguel and continued validation of the Sudbury Zero Tailings™ flowsheet as the Company seeks to scale its bioleaching and mine-waste remediation strategy.
- BacTech reported a net loss and comprehensive loss of C$1.8 million for 2025, compared with C$0.8 million in 2024, while total liabilities declined to C$3.2 million from C$4.8 million following financing activity and the settlement of convertible debenture obligations. At year-end, the Company had C$19,425 in cash and C$372,500 in marketable securities.
- BacTech’s leadership and technical team have decades of bioleaching and project-development experience, supported by research relationships such as MIRARCO in Sudbury. These capabilities strengthen the Company’s ability to advance its technology from pilot work toward commercial deployment.
*******************************************
Visit our Corporate Profile and Investment Highlights pages
for the latest research on BacTech Environmental Corporation
*******************************************